Gapping up
In reaction to strong earnings/guidance: HELE +8.2%, ATNY +1.8%
M&A news: DAEG +93% (Daegis to be acquired by Open Text (OTEX) for $0.82/share, or ~$13.5 mln in cash), UTIW +46.7% (to be acquired by DSV for $7.10 per share)
Select metals/mining stocks trading higher: ZINC +9.2%, MT +8.5%, HMY +6%, AU +5%, CLF +4.2%, FCX +4%, ABX +3.9%, GOLD +3.9%, GG +3.7%, PAAS +3.6%, VALE +3.6%, NEM +3.4%, HL +3.3%, GDX +3.2%, RIO +2.9%, X +2.6%, BBL +2.5%, BHP +1.8%, SLV +1.4%
Select oil/gas related names showing strength: PWE +6.4%, SDRL +6.1%, BBEP +2.9%, RIG +2.6%, WLL +1.8%, CHK +1.4%, TOT +1.3%, OAS +1.2%, BP +1.1%, VLO +1%.
Other news: ONTX +17.9% (entered into a $16.5 mln share purchase agreement with Lincoln Park Capital), PBMD +10.3% (receives ~EUR 306k in grant funding from the European Union and the German Free State of Saxony), TROV +8.2% ( presents results from a field experience analysis featuring the use of its Precision Cancer Monitoring platform to accurately identify mutational status), ACRX +8.1% (will make a presentation at the annual European Society of Emergency Medicine meeting; top-line results from the recently completed phase 3 study using sublingual sufentanil 30mcg tablets), TRCO +4.3% (co announced it has hired Eastdil Secured to begin exploring strategic monetization alternatives for Tribune Tower and adjacent land), ASNA +3.9% (Golden Gate Capital discloses 9% stake in 13D; believes significantly undervalued, offering meaningful upside with material downside protection ), PBR +3.9% (provides details on its projections for brent crude price and exchange rates, which it considered when adjusting its business and management plan earlier this week), ENB +3.5% (favorable commentary on Thursday's Mad Money), SSRI +3.1% (reported Q3 production of ~41,300 ounces of gold at Marigold mine; produced 2.6 mln ounces of silver at Pirquitas), UAL +3.1% (reported September consolidated traffic increased 1.4% and consolidated capacity increased 1.4% from prior year), SUNE +2.3% (cont volatility pre-mkt), TTM +1.8% (still checking), ADRO +1.7% ( receives Milestone Payment From Janssen (JNJ) for Submission of Investigational New Drug Application for ADU-214 in Lung Cancer), TWTR +1.4% (announces a new offering for Twitter Amplify related to monetization of video content), AAL +0.9% (reports Sept RPMs +7.2%)
Analyst comments: MT +9.1% (upgraded to Overweight from Neutral at JP Morgan), FEYE +2.3% (upgraded to Hold from Sell at Gabelli & Co), NLY +1.2% (upgraded to Mkt Perform at FBR Capital; upgraded to Neutral from Underperform at BofA/Merrill
)
In reaction to strong earnings/guidance: HELE +8.2%, ATNY +1.8%
M&A news: DAEG +93% (Daegis to be acquired by Open Text (OTEX) for $0.82/share, or ~$13.5 mln in cash), UTIW +46.7% (to be acquired by DSV for $7.10 per share)
Select metals/mining stocks trading higher: ZINC +9.2%, MT +8.5%, HMY +6%, AU +5%, CLF +4.2%, FCX +4%, ABX +3.9%, GOLD +3.9%, GG +3.7%, PAAS +3.6%, VALE +3.6%, NEM +3.4%, HL +3.3%, GDX +3.2%, RIO +2.9%, X +2.6%, BBL +2.5%, BHP +1.8%, SLV +1.4%
Select oil/gas related names showing strength: PWE +6.4%, SDRL +6.1%, BBEP +2.9%, RIG +2.6%, WLL +1.8%, CHK +1.4%, TOT +1.3%, OAS +1.2%, BP +1.1%, VLO +1%.
Other news: ONTX +17.9% (entered into a $16.5 mln share purchase agreement with Lincoln Park Capital), PBMD +10.3% (receives ~EUR 306k in grant funding from the European Union and the German Free State of Saxony), TROV +8.2% ( presents results from a field experience analysis featuring the use of its Precision Cancer Monitoring platform to accurately identify mutational status), ACRX +8.1% (will make a presentation at the annual European Society of Emergency Medicine meeting; top-line results from the recently completed phase 3 study using sublingual sufentanil 30mcg tablets), TRCO +4.3% (co announced it has hired Eastdil Secured to begin exploring strategic monetization alternatives for Tribune Tower and adjacent land), ASNA +3.9% (Golden Gate Capital discloses 9% stake in 13D; believes significantly undervalued, offering meaningful upside with material downside protection ), PBR +3.9% (provides details on its projections for brent crude price and exchange rates, which it considered when adjusting its business and management plan earlier this week), ENB +3.5% (favorable commentary on Thursday's Mad Money), SSRI +3.1% (reported Q3 production of ~41,300 ounces of gold at Marigold mine; produced 2.6 mln ounces of silver at Pirquitas), UAL +3.1% (reported September consolidated traffic increased 1.4% and consolidated capacity increased 1.4% from prior year), SUNE +2.3% (cont volatility pre-mkt), TTM +1.8% (still checking), ADRO +1.7% ( receives Milestone Payment From Janssen (JNJ) for Submission of Investigational New Drug Application for ADU-214 in Lung Cancer), TWTR +1.4% (announces a new offering for Twitter Amplify related to monetization of video content), AAL +0.9% (reports Sept RPMs +7.2%)
Analyst comments: MT +9.1% (upgraded to Overweight from Neutral at JP Morgan), FEYE +2.3% (upgraded to Hold from Sell at Gabelli & Co), NLY +1.2% (upgraded to Mkt Perform at FBR Capital; upgraded to Neutral from Underperform at BofA/Merrill
)